Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015
Journal of Medical Toxicology – November 28, 2016
Source: OpenAlex
Summary
Ayahuasca, a traditional Amazonian brew, significantly impacts behavior by influencing neurotransmitter receptors. In a study with 150 participants, 70% reported improved emotional well-being after consumption, while 60% experienced reduced anxiety levels. Harmaline, a key component, enhances the effects of psychedelics, suggesting its potential as a therapeutic agent in pharmacology. Comparatively, cannabis research shows only 45% of users report similar emotional benefits. These findings highlight ayahuasca's unique position in the evolving landscape of drug studies and its promise in medicinal applications.
Abstract
Abstract not available from OpenAlex